GPRIN2 Antikörper (N-Term)
-
- Target Alle GPRIN2 Antikörper anzeigen
- GPRIN2 (G Protein Regulated Inducer of Neurite Outgrowth 2 (GPRIN2))
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human, Meerschweinchen, Ratte, Saccharomyces cerevisiae
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GPRIN2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- LSQSSSSLLG EGREQRPELR KTASSTVWQA QLGEASTRPQ APEEEGNPPE
- Homologie
- Guinea Pig: 93%, Human: 100%, Rat: 92%, Yeast: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against GPRIN2. It was validated on Western Blot.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the N-terminal region of Human GPRIN2
- Top Product
- Discover our top product GPRIN2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 461 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
- Target
- GPRIN2 (G Protein Regulated Inducer of Neurite Outgrowth 2 (GPRIN2))
- Andere Bezeichnung
- GPRIN2 (GPRIN2 Produkte)
- Hintergrund
-
GPRIN2 may be involved in neurite outgrowth.
Alias Symbols: GRIN2, KIAA0514, MGC15171
Protein Interaction Partner: KRTAP10-3, KRTAP12-1, DYNLL2, KRTAP4-7, BCAP31, Hoxa1, KRTAP4-12, PLSCR1, MDFI, YWHAE, TRIP13, SPRY2, SFN,
Protein Size: 461 - Molekulargewicht
- 51 kDa
- Gen-ID
- 9721
- NCBI Accession
- NM_014696, NP_055511
-